Patent · US Active

Treatment of graft versus host disease in transplant patients

US11224604B2 · kind B2 · utility

0Cited by

6References

16Claims

0Family size

Assignee

PRIOTHERA LIMITED · IE

Inventors

Peter Gergely · Oberwil, CH
Kazuhiko Kuriyama · Tochigi, JP

Key dates

Filing date	Jan 29, 2018
Grant date	Jan 18, 2022
Priority date	—
Expiry date	Dec 23, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/124
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of treating patients who undergo hematopoietic stem cell transplantation (HSCT) with peripheral blood mobilized stem cells for hematological malignancies and for whom the risk for severe acute graft versus host disease (GVHD) is considerable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.